Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132

NCT02130765 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02130765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2014
Completion date
July 25, 2016
Enrollment
64 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

monomorphic ventricular tachycardia